Global Positive Allosteric Modulators Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Positive Allosteric Modulators Industry Forecast” looks at past sales and reviews total world Positive Allosteric Modulators sales in 2022, providing a comprehensive analysis by region and market sector of projected Positive Allosteric Modulators sales for 2023 through 2029. With Positive Allosteric Modulators sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Positive Allosteric Modulators industry.
This Insight Report provides a comprehensive analysis of the global Positive Allosteric Modulators landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Positive Allosteric Modulators portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Positive Allosteric Modulators market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Positive Allosteric Modulators and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Positive Allosteric Modulators.
The global Positive Allosteric Modulators market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Positive Allosteric Modulators is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Positive Allosteric Modulators is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Positive Allosteric Modulators is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Positive Allosteric Modulators players cover F. Hoffmann-La Roche, Pfizer, Taj Pharmaceuticals, Explicit Chemicals, Shaanxi Rebecca Bio-Tech, Zydus Cadila, ACADIA Pharmaceuticals, M Somerset Pharmaceuticals and Vertical Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Positive Allosteric Modulators market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Positive Allosteric Modulators market?
What factors are driving Positive Allosteric Modulators market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Positive Allosteric Modulators market opportunities vary by end market size?
How does Positive Allosteric Modulators break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Positive Allosteric Modulators Industry Forecast” looks at past sales and reviews total world Positive Allosteric Modulators sales in 2022, providing a comprehensive analysis by region and market sector of projected Positive Allosteric Modulators sales for 2023 through 2029. With Positive Allosteric Modulators sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Positive Allosteric Modulators industry.
This Insight Report provides a comprehensive analysis of the global Positive Allosteric Modulators landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Positive Allosteric Modulators portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Positive Allosteric Modulators market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Positive Allosteric Modulators and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Positive Allosteric Modulators.
The global Positive Allosteric Modulators market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Positive Allosteric Modulators is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Positive Allosteric Modulators is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Positive Allosteric Modulators is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Positive Allosteric Modulators players cover F. Hoffmann-La Roche, Pfizer, Taj Pharmaceuticals, Explicit Chemicals, Shaanxi Rebecca Bio-Tech, Zydus Cadila, ACADIA Pharmaceuticals, M Somerset Pharmaceuticals and Vertical Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Positive Allosteric Modulators market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Benzodiazepines
- Barbiturates
- Amantadine
- Other
- Parkinson’s Disease
- Schizophrenia
- Alzheimer’s Disease
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- F. Hoffmann-La Roche
- Pfizer
- Taj Pharmaceuticals
- Explicit Chemicals
- Shaanxi Rebecca Bio-Tech
- Zydus Cadila
- ACADIA Pharmaceuticals
- M Somerset Pharmaceuticals
- Vertical Pharmaceuticals
What is the 10-year outlook for the global Positive Allosteric Modulators market?
What factors are driving Positive Allosteric Modulators market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Positive Allosteric Modulators market opportunities vary by end market size?
How does Positive Allosteric Modulators break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Positive Allosteric Modulators Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Positive Allosteric Modulators by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Positive Allosteric Modulators by Country/Region, 2018, 2022 & 2029
2.2 Positive Allosteric Modulators Segment by Type
2.2.1 Benzodiazepines
2.2.2 Barbiturates
2.2.3 Amantadine
2.2.4 Other
2.3 Positive Allosteric Modulators Sales by Type
2.3.1 Global Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
2.3.2 Global Positive Allosteric Modulators Revenue and Market Share by Type (2018-2023)
2.3.3 Global Positive Allosteric Modulators Sale Price by Type (2018-2023)
2.4 Positive Allosteric Modulators Segment by Application
2.4.1 Parkinson’s Disease
2.4.2 Schizophrenia
2.4.3 Alzheimer’s Disease
2.5 Positive Allosteric Modulators Sales by Application
2.5.1 Global Positive Allosteric Modulators Sale Market Share by Application (2018-2023)
2.5.2 Global Positive Allosteric Modulators Revenue and Market Share by Application (2018-2023)
2.5.3 Global Positive Allosteric Modulators Sale Price by Application (2018-2023)
3 GLOBAL POSITIVE ALLOSTERIC MODULATORS BY COMPANY
3.1 Global Positive Allosteric Modulators Breakdown Data by Company
3.1.1 Global Positive Allosteric Modulators Annual Sales by Company (2018-2023)
3.1.2 Global Positive Allosteric Modulators Sales Market Share by Company (2018-2023)
3.2 Global Positive Allosteric Modulators Annual Revenue by Company (2018-2023)
3.2.1 Global Positive Allosteric Modulators Revenue by Company (2018-2023)
3.2.2 Global Positive Allosteric Modulators Revenue Market Share by Company (2018-2023)
3.3 Global Positive Allosteric Modulators Sale Price by Company
3.4 Key Manufacturers Positive Allosteric Modulators Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Positive Allosteric Modulators Product Location Distribution
3.4.2 Players Positive Allosteric Modulators Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POSITIVE ALLOSTERIC MODULATORS BY GEOGRAPHIC REGION
4.1 World Historic Positive Allosteric Modulators Market Size by Geographic Region (2018-2023)
4.1.1 Global Positive Allosteric Modulators Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Positive Allosteric Modulators Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Positive Allosteric Modulators Market Size by Country/Region (2018-2023)
4.2.1 Global Positive Allosteric Modulators Annual Sales by Country/Region (2018-2023)
4.2.2 Global Positive Allosteric Modulators Annual Revenue by Country/Region (2018-2023)
4.3 Americas Positive Allosteric Modulators Sales Growth
4.4 APAC Positive Allosteric Modulators Sales Growth
4.5 Europe Positive Allosteric Modulators Sales Growth
4.6 Middle East & Africa Positive Allosteric Modulators Sales Growth
5 AMERICAS
5.1 Americas Positive Allosteric Modulators Sales by Country
5.1.1 Americas Positive Allosteric Modulators Sales by Country (2018-2023)
5.1.2 Americas Positive Allosteric Modulators Revenue by Country (2018-2023)
5.2 Americas Positive Allosteric Modulators Sales by Type
5.3 Americas Positive Allosteric Modulators Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Positive Allosteric Modulators Sales by Region
6.1.1 APAC Positive Allosteric Modulators Sales by Region (2018-2023)
6.1.2 APAC Positive Allosteric Modulators Revenue by Region (2018-2023)
6.2 APAC Positive Allosteric Modulators Sales by Type
6.3 APAC Positive Allosteric Modulators Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Positive Allosteric Modulators by Country
7.1.1 Europe Positive Allosteric Modulators Sales by Country (2018-2023)
7.1.2 Europe Positive Allosteric Modulators Revenue by Country (2018-2023)
7.2 Europe Positive Allosteric Modulators Sales by Type
7.3 Europe Positive Allosteric Modulators Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Positive Allosteric Modulators by Country
8.1.1 Middle East & Africa Positive Allosteric Modulators Sales by Country (2018-2023)
8.1.2 Middle East & Africa Positive Allosteric Modulators Revenue by Country (2018-2023)
8.2 Middle East & Africa Positive Allosteric Modulators Sales by Type
8.3 Middle East & Africa Positive Allosteric Modulators Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Positive Allosteric Modulators
10.3 Manufacturing Process Analysis of Positive Allosteric Modulators
10.4 Industry Chain Structure of Positive Allosteric Modulators
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Positive Allosteric Modulators Distributors
11.3 Positive Allosteric Modulators Customer
12 WORLD FORECAST REVIEW FOR POSITIVE ALLOSTERIC MODULATORS BY GEOGRAPHIC REGION
12.1 Global Positive Allosteric Modulators Market Size Forecast by Region
12.1.1 Global Positive Allosteric Modulators Forecast by Region (2024-2029)
12.1.2 Global Positive Allosteric Modulators Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Positive Allosteric Modulators Forecast by Type
12.7 Global Positive Allosteric Modulators Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Information
13.1.2 F. Hoffmann-La Roche Positive Allosteric Modulators Product Portfolios and Specifications
13.1.3 F. Hoffmann-La Roche Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 F. Hoffmann-La Roche Main Business Overview
13.1.5 F. Hoffmann-La Roche Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Positive Allosteric Modulators Product Portfolios and Specifications
13.2.3 Pfizer Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Taj Pharmaceuticals
13.3.1 Taj Pharmaceuticals Company Information
13.3.2 Taj Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
13.3.3 Taj Pharmaceuticals Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Taj Pharmaceuticals Main Business Overview
13.3.5 Taj Pharmaceuticals Latest Developments
13.4 Explicit Chemicals
13.4.1 Explicit Chemicals Company Information
13.4.2 Explicit Chemicals Positive Allosteric Modulators Product Portfolios and Specifications
13.4.3 Explicit Chemicals Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Explicit Chemicals Main Business Overview
13.4.5 Explicit Chemicals Latest Developments
13.5 Shaanxi Rebecca Bio-Tech
13.5.1 Shaanxi Rebecca Bio-Tech Company Information
13.5.2 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Product Portfolios and Specifications
13.5.3 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Shaanxi Rebecca Bio-Tech Main Business Overview
13.5.5 Shaanxi Rebecca Bio-Tech Latest Developments
13.6 Zydus Cadila
13.6.1 Zydus Cadila Company Information
13.6.2 Zydus Cadila Positive Allosteric Modulators Product Portfolios and Specifications
13.6.3 Zydus Cadila Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Zydus Cadila Main Business Overview
13.6.5 Zydus Cadila Latest Developments
13.7 ACADIA Pharmaceuticals
13.7.1 ACADIA Pharmaceuticals Company Information
13.7.2 ACADIA Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
13.7.3 ACADIA Pharmaceuticals Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 ACADIA Pharmaceuticals Main Business Overview
13.7.5 ACADIA Pharmaceuticals Latest Developments
13.8 M Somerset Pharmaceuticals
13.8.1 M Somerset Pharmaceuticals Company Information
13.8.2 M Somerset Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
13.8.3 M Somerset Pharmaceuticals Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 M Somerset Pharmaceuticals Main Business Overview
13.8.5 M Somerset Pharmaceuticals Latest Developments
13.9 Vertical Pharmaceuticals
13.9.1 Vertical Pharmaceuticals Company Information
13.9.2 Vertical Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
13.9.3 Vertical Pharmaceuticals Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Vertical Pharmaceuticals Main Business Overview
13.9.5 Vertical Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Positive Allosteric Modulators Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Positive Allosteric Modulators by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Positive Allosteric Modulators by Country/Region, 2018, 2022 & 2029
2.2 Positive Allosteric Modulators Segment by Type
2.2.1 Benzodiazepines
2.2.2 Barbiturates
2.2.3 Amantadine
2.2.4 Other
2.3 Positive Allosteric Modulators Sales by Type
2.3.1 Global Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
2.3.2 Global Positive Allosteric Modulators Revenue and Market Share by Type (2018-2023)
2.3.3 Global Positive Allosteric Modulators Sale Price by Type (2018-2023)
2.4 Positive Allosteric Modulators Segment by Application
2.4.1 Parkinson’s Disease
2.4.2 Schizophrenia
2.4.3 Alzheimer’s Disease
2.5 Positive Allosteric Modulators Sales by Application
2.5.1 Global Positive Allosteric Modulators Sale Market Share by Application (2018-2023)
2.5.2 Global Positive Allosteric Modulators Revenue and Market Share by Application (2018-2023)
2.5.3 Global Positive Allosteric Modulators Sale Price by Application (2018-2023)
3 GLOBAL POSITIVE ALLOSTERIC MODULATORS BY COMPANY
3.1 Global Positive Allosteric Modulators Breakdown Data by Company
3.1.1 Global Positive Allosteric Modulators Annual Sales by Company (2018-2023)
3.1.2 Global Positive Allosteric Modulators Sales Market Share by Company (2018-2023)
3.2 Global Positive Allosteric Modulators Annual Revenue by Company (2018-2023)
3.2.1 Global Positive Allosteric Modulators Revenue by Company (2018-2023)
3.2.2 Global Positive Allosteric Modulators Revenue Market Share by Company (2018-2023)
3.3 Global Positive Allosteric Modulators Sale Price by Company
3.4 Key Manufacturers Positive Allosteric Modulators Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Positive Allosteric Modulators Product Location Distribution
3.4.2 Players Positive Allosteric Modulators Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POSITIVE ALLOSTERIC MODULATORS BY GEOGRAPHIC REGION
4.1 World Historic Positive Allosteric Modulators Market Size by Geographic Region (2018-2023)
4.1.1 Global Positive Allosteric Modulators Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Positive Allosteric Modulators Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Positive Allosteric Modulators Market Size by Country/Region (2018-2023)
4.2.1 Global Positive Allosteric Modulators Annual Sales by Country/Region (2018-2023)
4.2.2 Global Positive Allosteric Modulators Annual Revenue by Country/Region (2018-2023)
4.3 Americas Positive Allosteric Modulators Sales Growth
4.4 APAC Positive Allosteric Modulators Sales Growth
4.5 Europe Positive Allosteric Modulators Sales Growth
4.6 Middle East & Africa Positive Allosteric Modulators Sales Growth
5 AMERICAS
5.1 Americas Positive Allosteric Modulators Sales by Country
5.1.1 Americas Positive Allosteric Modulators Sales by Country (2018-2023)
5.1.2 Americas Positive Allosteric Modulators Revenue by Country (2018-2023)
5.2 Americas Positive Allosteric Modulators Sales by Type
5.3 Americas Positive Allosteric Modulators Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Positive Allosteric Modulators Sales by Region
6.1.1 APAC Positive Allosteric Modulators Sales by Region (2018-2023)
6.1.2 APAC Positive Allosteric Modulators Revenue by Region (2018-2023)
6.2 APAC Positive Allosteric Modulators Sales by Type
6.3 APAC Positive Allosteric Modulators Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Positive Allosteric Modulators by Country
7.1.1 Europe Positive Allosteric Modulators Sales by Country (2018-2023)
7.1.2 Europe Positive Allosteric Modulators Revenue by Country (2018-2023)
7.2 Europe Positive Allosteric Modulators Sales by Type
7.3 Europe Positive Allosteric Modulators Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Positive Allosteric Modulators by Country
8.1.1 Middle East & Africa Positive Allosteric Modulators Sales by Country (2018-2023)
8.1.2 Middle East & Africa Positive Allosteric Modulators Revenue by Country (2018-2023)
8.2 Middle East & Africa Positive Allosteric Modulators Sales by Type
8.3 Middle East & Africa Positive Allosteric Modulators Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Positive Allosteric Modulators
10.3 Manufacturing Process Analysis of Positive Allosteric Modulators
10.4 Industry Chain Structure of Positive Allosteric Modulators
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Positive Allosteric Modulators Distributors
11.3 Positive Allosteric Modulators Customer
12 WORLD FORECAST REVIEW FOR POSITIVE ALLOSTERIC MODULATORS BY GEOGRAPHIC REGION
12.1 Global Positive Allosteric Modulators Market Size Forecast by Region
12.1.1 Global Positive Allosteric Modulators Forecast by Region (2024-2029)
12.1.2 Global Positive Allosteric Modulators Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Positive Allosteric Modulators Forecast by Type
12.7 Global Positive Allosteric Modulators Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Information
13.1.2 F. Hoffmann-La Roche Positive Allosteric Modulators Product Portfolios and Specifications
13.1.3 F. Hoffmann-La Roche Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 F. Hoffmann-La Roche Main Business Overview
13.1.5 F. Hoffmann-La Roche Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Positive Allosteric Modulators Product Portfolios and Specifications
13.2.3 Pfizer Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Taj Pharmaceuticals
13.3.1 Taj Pharmaceuticals Company Information
13.3.2 Taj Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
13.3.3 Taj Pharmaceuticals Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Taj Pharmaceuticals Main Business Overview
13.3.5 Taj Pharmaceuticals Latest Developments
13.4 Explicit Chemicals
13.4.1 Explicit Chemicals Company Information
13.4.2 Explicit Chemicals Positive Allosteric Modulators Product Portfolios and Specifications
13.4.3 Explicit Chemicals Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Explicit Chemicals Main Business Overview
13.4.5 Explicit Chemicals Latest Developments
13.5 Shaanxi Rebecca Bio-Tech
13.5.1 Shaanxi Rebecca Bio-Tech Company Information
13.5.2 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Product Portfolios and Specifications
13.5.3 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Shaanxi Rebecca Bio-Tech Main Business Overview
13.5.5 Shaanxi Rebecca Bio-Tech Latest Developments
13.6 Zydus Cadila
13.6.1 Zydus Cadila Company Information
13.6.2 Zydus Cadila Positive Allosteric Modulators Product Portfolios and Specifications
13.6.3 Zydus Cadila Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Zydus Cadila Main Business Overview
13.6.5 Zydus Cadila Latest Developments
13.7 ACADIA Pharmaceuticals
13.7.1 ACADIA Pharmaceuticals Company Information
13.7.2 ACADIA Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
13.7.3 ACADIA Pharmaceuticals Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 ACADIA Pharmaceuticals Main Business Overview
13.7.5 ACADIA Pharmaceuticals Latest Developments
13.8 M Somerset Pharmaceuticals
13.8.1 M Somerset Pharmaceuticals Company Information
13.8.2 M Somerset Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
13.8.3 M Somerset Pharmaceuticals Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 M Somerset Pharmaceuticals Main Business Overview
13.8.5 M Somerset Pharmaceuticals Latest Developments
13.9 Vertical Pharmaceuticals
13.9.1 Vertical Pharmaceuticals Company Information
13.9.2 Vertical Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
13.9.3 Vertical Pharmaceuticals Positive Allosteric Modulators Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Vertical Pharmaceuticals Main Business Overview
13.9.5 Vertical Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Positive Allosteric Modulators Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Positive Allosteric Modulators Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Benzodiazepines
Table 4. Major Players of Barbiturates
Table 5. Major Players of Amantadine
Table 6. Major Players of Other
Table 7. Global Positive Allosteric Modulators Sales by Type (2018-2023) & (Kiloton)
Table 8. Global Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
Table 9. Global Positive Allosteric Modulators Revenue by Type (2018-2023) & ($ million)
Table 10. Global Positive Allosteric Modulators Revenue Market Share by Type (2018-2023)
Table 11. Global Positive Allosteric Modulators Sale Price by Type (2018-2023) & (US$/Ton)
Table 12. Global Positive Allosteric Modulators Sales by Application (2018-2023) & (Kiloton)
Table 13. Global Positive Allosteric Modulators Sales Market Share by Application (2018-2023)
Table 14. Global Positive Allosteric Modulators Revenue by Application (2018-2023)
Table 15. Global Positive Allosteric Modulators Revenue Market Share by Application (2018-2023)
Table 16. Global Positive Allosteric Modulators Sale Price by Application (2018-2023) & (US$/Ton)
Table 17. Global Positive Allosteric Modulators Sales by Company (2018-2023) & (Kiloton)
Table 18. Global Positive Allosteric Modulators Sales Market Share by Company (2018-2023)
Table 19. Global Positive Allosteric Modulators Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Positive Allosteric Modulators Revenue Market Share by Company (2018-2023)
Table 21. Global Positive Allosteric Modulators Sale Price by Company (2018-2023) & (US$/Ton)
Table 22. Key Manufacturers Positive Allosteric Modulators Producing Area Distribution and Sales Area
Table 23. Players Positive Allosteric Modulators Products Offered
Table 24. Positive Allosteric Modulators Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Positive Allosteric Modulators Sales by Geographic Region (2018-2023) & (Kiloton)
Table 28. Global Positive Allosteric Modulators Sales Market Share Geographic Region (2018-2023)
Table 29. Global Positive Allosteric Modulators Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Positive Allosteric Modulators Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Positive Allosteric Modulators Sales by Country/Region (2018-2023) & (Kiloton)
Table 32. Global Positive Allosteric Modulators Sales Market Share by Country/Region (2018-2023)
Table 33. Global Positive Allosteric Modulators Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Positive Allosteric Modulators Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Positive Allosteric Modulators Sales by Country (2018-2023) & (Kiloton)
Table 36. Americas Positive Allosteric Modulators Sales Market Share by Country (2018-2023)
Table 37. Americas Positive Allosteric Modulators Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Positive Allosteric Modulators Revenue Market Share by Country (2018-2023)
Table 39. Americas Positive Allosteric Modulators Sales by Type (2018-2023) & (Kiloton)
Table 40. Americas Positive Allosteric Modulators Sales by Application (2018-2023) & (Kiloton)
Table 41. APAC Positive Allosteric Modulators Sales by Region (2018-2023) & (Kiloton)
Table 42. APAC Positive Allosteric Modulators Sales Market Share by Region (2018-2023)
Table 43. APAC Positive Allosteric Modulators Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Positive Allosteric Modulators Revenue Market Share by Region (2018-2023)
Table 45. APAC Positive Allosteric Modulators Sales by Type (2018-2023) & (Kiloton)
Table 46. APAC Positive Allosteric Modulators Sales by Application (2018-2023) & (Kiloton)
Table 47. Europe Positive Allosteric Modulators Sales by Country (2018-2023) & (Kiloton)
Table 48. Europe Positive Allosteric Modulators Sales Market Share by Country (2018-2023)
Table 49. Europe Positive Allosteric Modulators Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Positive Allosteric Modulators Revenue Market Share by Country (2018-2023)
Table 51. Europe Positive Allosteric Modulators Sales by Type (2018-2023) & (Kiloton)
Table 52. Europe Positive Allosteric Modulators Sales by Application (2018-2023) & (Kiloton)
Table 53. Middle East & Africa Positive Allosteric Modulators Sales by Country (2018-2023) & (Kiloton)
Table 54. Middle East & Africa Positive Allosteric Modulators Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Positive Allosteric Modulators Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Positive Allosteric Modulators Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Positive Allosteric Modulators Sales by Type (2018-2023) & (Kiloton)
Table 58. Middle East & Africa Positive Allosteric Modulators Sales by Application (2018-2023) & (Kiloton)
Table 59. Key Market Drivers & Growth Opportunities of Positive Allosteric Modulators
Table 60. Key Market Challenges & Risks of Positive Allosteric Modulators
Table 61. Key Industry Trends of Positive Allosteric Modulators
Table 62. Positive Allosteric Modulators Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Positive Allosteric Modulators Distributors List
Table 65. Positive Allosteric Modulators Customer List
Table 66. Global Positive Allosteric Modulators Sales Forecast by Region (2024-2029) & (Kiloton)
Table 67. Global Positive Allosteric Modulators Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Positive Allosteric Modulators Sales Forecast by Country (2024-2029) & (Kiloton)
Table 69. Americas Positive Allosteric Modulators Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Positive Allosteric Modulators Sales Forecast by Region (2024-2029) & (Kiloton)
Table 71. APAC Positive Allosteric Modulators Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Positive Allosteric Modulators Sales Forecast by Country (2024-2029) & (Kiloton)
Table 73. Europe Positive Allosteric Modulators Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Positive Allosteric Modulators Sales Forecast by Country (2024-2029) & (Kiloton)
Table 75. Middle East & Africa Positive Allosteric Modulators Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Positive Allosteric Modulators Sales Forecast by Type (2024-2029) & (Kiloton)
Table 77. Global Positive Allosteric Modulators Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Positive Allosteric Modulators Sales Forecast by Application (2024-2029) & (Kiloton)
Table 79. Global Positive Allosteric Modulators Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. F. Hoffmann-La Roche Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 81. F. Hoffmann-La Roche Positive Allosteric Modulators Product Portfolios and Specifications
Table 82. F. Hoffmann-La Roche Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 83. F. Hoffmann-La Roche Main Business
Table 84. F. Hoffmann-La Roche Latest Developments
Table 85. Pfizer Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Positive Allosteric Modulators Product Portfolios and Specifications
Table 87. Pfizer Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 88. Pfizer Main Business
Table 89. Pfizer Latest Developments
Table 90. Taj Pharmaceuticals Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 91. Taj Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
Table 92. Taj Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 93. Taj Pharmaceuticals Main Business
Table 94. Taj Pharmaceuticals Latest Developments
Table 95. Explicit Chemicals Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 96. Explicit Chemicals Positive Allosteric Modulators Product Portfolios and Specifications
Table 97. Explicit Chemicals Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 98. Explicit Chemicals Main Business
Table 99. Explicit Chemicals Latest Developments
Table 100. Shaanxi Rebecca Bio-Tech Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 101. Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Product Portfolios and Specifications
Table 102. Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 103. Shaanxi Rebecca Bio-Tech Main Business
Table 104. Shaanxi Rebecca Bio-Tech Latest Developments
Table 105. Zydus Cadila Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 106. Zydus Cadila Positive Allosteric Modulators Product Portfolios and Specifications
Table 107. Zydus Cadila Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 108. Zydus Cadila Main Business
Table 109. Zydus Cadila Latest Developments
Table 110. ACADIA Pharmaceuticals Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 111. ACADIA Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
Table 112. ACADIA Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 113. ACADIA Pharmaceuticals Main Business
Table 114. ACADIA Pharmaceuticals Latest Developments
Table 115. M Somerset Pharmaceuticals Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 116. M Somerset Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
Table 117. M Somerset Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 118. M Somerset Pharmaceuticals Main Business
Table 119. M Somerset Pharmaceuticals Latest Developments
Table 120. Vertical Pharmaceuticals Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 121. Vertical Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
Table 122. Vertical Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 123. Vertical Pharmaceuticals Main Business
Table 124. Vertical Pharmaceuticals Latest Developments
Table 1. Positive Allosteric Modulators Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Positive Allosteric Modulators Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Benzodiazepines
Table 4. Major Players of Barbiturates
Table 5. Major Players of Amantadine
Table 6. Major Players of Other
Table 7. Global Positive Allosteric Modulators Sales by Type (2018-2023) & (Kiloton)
Table 8. Global Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
Table 9. Global Positive Allosteric Modulators Revenue by Type (2018-2023) & ($ million)
Table 10. Global Positive Allosteric Modulators Revenue Market Share by Type (2018-2023)
Table 11. Global Positive Allosteric Modulators Sale Price by Type (2018-2023) & (US$/Ton)
Table 12. Global Positive Allosteric Modulators Sales by Application (2018-2023) & (Kiloton)
Table 13. Global Positive Allosteric Modulators Sales Market Share by Application (2018-2023)
Table 14. Global Positive Allosteric Modulators Revenue by Application (2018-2023)
Table 15. Global Positive Allosteric Modulators Revenue Market Share by Application (2018-2023)
Table 16. Global Positive Allosteric Modulators Sale Price by Application (2018-2023) & (US$/Ton)
Table 17. Global Positive Allosteric Modulators Sales by Company (2018-2023) & (Kiloton)
Table 18. Global Positive Allosteric Modulators Sales Market Share by Company (2018-2023)
Table 19. Global Positive Allosteric Modulators Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Positive Allosteric Modulators Revenue Market Share by Company (2018-2023)
Table 21. Global Positive Allosteric Modulators Sale Price by Company (2018-2023) & (US$/Ton)
Table 22. Key Manufacturers Positive Allosteric Modulators Producing Area Distribution and Sales Area
Table 23. Players Positive Allosteric Modulators Products Offered
Table 24. Positive Allosteric Modulators Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Positive Allosteric Modulators Sales by Geographic Region (2018-2023) & (Kiloton)
Table 28. Global Positive Allosteric Modulators Sales Market Share Geographic Region (2018-2023)
Table 29. Global Positive Allosteric Modulators Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Positive Allosteric Modulators Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Positive Allosteric Modulators Sales by Country/Region (2018-2023) & (Kiloton)
Table 32. Global Positive Allosteric Modulators Sales Market Share by Country/Region (2018-2023)
Table 33. Global Positive Allosteric Modulators Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Positive Allosteric Modulators Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Positive Allosteric Modulators Sales by Country (2018-2023) & (Kiloton)
Table 36. Americas Positive Allosteric Modulators Sales Market Share by Country (2018-2023)
Table 37. Americas Positive Allosteric Modulators Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Positive Allosteric Modulators Revenue Market Share by Country (2018-2023)
Table 39. Americas Positive Allosteric Modulators Sales by Type (2018-2023) & (Kiloton)
Table 40. Americas Positive Allosteric Modulators Sales by Application (2018-2023) & (Kiloton)
Table 41. APAC Positive Allosteric Modulators Sales by Region (2018-2023) & (Kiloton)
Table 42. APAC Positive Allosteric Modulators Sales Market Share by Region (2018-2023)
Table 43. APAC Positive Allosteric Modulators Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Positive Allosteric Modulators Revenue Market Share by Region (2018-2023)
Table 45. APAC Positive Allosteric Modulators Sales by Type (2018-2023) & (Kiloton)
Table 46. APAC Positive Allosteric Modulators Sales by Application (2018-2023) & (Kiloton)
Table 47. Europe Positive Allosteric Modulators Sales by Country (2018-2023) & (Kiloton)
Table 48. Europe Positive Allosteric Modulators Sales Market Share by Country (2018-2023)
Table 49. Europe Positive Allosteric Modulators Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Positive Allosteric Modulators Revenue Market Share by Country (2018-2023)
Table 51. Europe Positive Allosteric Modulators Sales by Type (2018-2023) & (Kiloton)
Table 52. Europe Positive Allosteric Modulators Sales by Application (2018-2023) & (Kiloton)
Table 53. Middle East & Africa Positive Allosteric Modulators Sales by Country (2018-2023) & (Kiloton)
Table 54. Middle East & Africa Positive Allosteric Modulators Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Positive Allosteric Modulators Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Positive Allosteric Modulators Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Positive Allosteric Modulators Sales by Type (2018-2023) & (Kiloton)
Table 58. Middle East & Africa Positive Allosteric Modulators Sales by Application (2018-2023) & (Kiloton)
Table 59. Key Market Drivers & Growth Opportunities of Positive Allosteric Modulators
Table 60. Key Market Challenges & Risks of Positive Allosteric Modulators
Table 61. Key Industry Trends of Positive Allosteric Modulators
Table 62. Positive Allosteric Modulators Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Positive Allosteric Modulators Distributors List
Table 65. Positive Allosteric Modulators Customer List
Table 66. Global Positive Allosteric Modulators Sales Forecast by Region (2024-2029) & (Kiloton)
Table 67. Global Positive Allosteric Modulators Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Positive Allosteric Modulators Sales Forecast by Country (2024-2029) & (Kiloton)
Table 69. Americas Positive Allosteric Modulators Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Positive Allosteric Modulators Sales Forecast by Region (2024-2029) & (Kiloton)
Table 71. APAC Positive Allosteric Modulators Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Positive Allosteric Modulators Sales Forecast by Country (2024-2029) & (Kiloton)
Table 73. Europe Positive Allosteric Modulators Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Positive Allosteric Modulators Sales Forecast by Country (2024-2029) & (Kiloton)
Table 75. Middle East & Africa Positive Allosteric Modulators Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Positive Allosteric Modulators Sales Forecast by Type (2024-2029) & (Kiloton)
Table 77. Global Positive Allosteric Modulators Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Positive Allosteric Modulators Sales Forecast by Application (2024-2029) & (Kiloton)
Table 79. Global Positive Allosteric Modulators Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. F. Hoffmann-La Roche Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 81. F. Hoffmann-La Roche Positive Allosteric Modulators Product Portfolios and Specifications
Table 82. F. Hoffmann-La Roche Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 83. F. Hoffmann-La Roche Main Business
Table 84. F. Hoffmann-La Roche Latest Developments
Table 85. Pfizer Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Positive Allosteric Modulators Product Portfolios and Specifications
Table 87. Pfizer Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 88. Pfizer Main Business
Table 89. Pfizer Latest Developments
Table 90. Taj Pharmaceuticals Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 91. Taj Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
Table 92. Taj Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 93. Taj Pharmaceuticals Main Business
Table 94. Taj Pharmaceuticals Latest Developments
Table 95. Explicit Chemicals Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 96. Explicit Chemicals Positive Allosteric Modulators Product Portfolios and Specifications
Table 97. Explicit Chemicals Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 98. Explicit Chemicals Main Business
Table 99. Explicit Chemicals Latest Developments
Table 100. Shaanxi Rebecca Bio-Tech Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 101. Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Product Portfolios and Specifications
Table 102. Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 103. Shaanxi Rebecca Bio-Tech Main Business
Table 104. Shaanxi Rebecca Bio-Tech Latest Developments
Table 105. Zydus Cadila Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 106. Zydus Cadila Positive Allosteric Modulators Product Portfolios and Specifications
Table 107. Zydus Cadila Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 108. Zydus Cadila Main Business
Table 109. Zydus Cadila Latest Developments
Table 110. ACADIA Pharmaceuticals Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 111. ACADIA Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
Table 112. ACADIA Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 113. ACADIA Pharmaceuticals Main Business
Table 114. ACADIA Pharmaceuticals Latest Developments
Table 115. M Somerset Pharmaceuticals Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 116. M Somerset Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
Table 117. M Somerset Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 118. M Somerset Pharmaceuticals Main Business
Table 119. M Somerset Pharmaceuticals Latest Developments
Table 120. Vertical Pharmaceuticals Basic Information, Positive Allosteric Modulators Manufacturing Base, Sales Area and Its Competitors
Table 121. Vertical Pharmaceuticals Positive Allosteric Modulators Product Portfolios and Specifications
Table 122. Vertical Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 123. Vertical Pharmaceuticals Main Business
Table 124. Vertical Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Positive Allosteric Modulators
Figure 2. Positive Allosteric Modulators Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Positive Allosteric Modulators Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Positive Allosteric Modulators Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Positive Allosteric Modulators Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Benzodiazepines
Figure 10. Product Picture of Barbiturates
Figure 11. Product Picture of Amantadine
Figure 12. Product Picture of Other
Figure 13. Global Positive Allosteric Modulators Sales Market Share by Type in 2022
Figure 14. Global Positive Allosteric Modulators Revenue Market Share by Type (2018-2023)
Figure 15. Positive Allosteric Modulators Consumed in Parkinson’s Disease
Figure 16. Global Positive Allosteric Modulators Market: Parkinson’s Disease (2018-2023) & (Kiloton)
Figure 17. Positive Allosteric Modulators Consumed in Schizophrenia
Figure 18. Global Positive Allosteric Modulators Market: Schizophrenia (2018-2023) & (Kiloton)
Figure 19. Positive Allosteric Modulators Consumed in Alzheimer’s Disease
Figure 20. Global Positive Allosteric Modulators Market: Alzheimer’s Disease (2018-2023) & (Kiloton)
Figure 21. Global Positive Allosteric Modulators Sales Market Share by Application (2022)
Figure 22. Global Positive Allosteric Modulators Revenue Market Share by Application in 2022
Figure 23. Positive Allosteric Modulators Sales Market by Company in 2022 (Kiloton)
Figure 24. Global Positive Allosteric Modulators Sales Market Share by Company in 2022
Figure 25. Positive Allosteric Modulators Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Positive Allosteric Modulators Revenue Market Share by Company in 2022
Figure 27. Global Positive Allosteric Modulators Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Positive Allosteric Modulators Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Positive Allosteric Modulators Sales 2018-2023 (Kiloton)
Figure 30. Americas Positive Allosteric Modulators Revenue 2018-2023 ($ Millions)
Figure 31. APAC Positive Allosteric Modulators Sales 2018-2023 (Kiloton)
Figure 32. APAC Positive Allosteric Modulators Revenue 2018-2023 ($ Millions)
Figure 33. Europe Positive Allosteric Modulators Sales 2018-2023 (Kiloton)
Figure 34. Europe Positive Allosteric Modulators Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Positive Allosteric Modulators Sales 2018-2023 (Kiloton)
Figure 36. Middle East & Africa Positive Allosteric Modulators Revenue 2018-2023 ($ Millions)
Figure 37. Americas Positive Allosteric Modulators Sales Market Share by Country in 2022
Figure 38. Americas Positive Allosteric Modulators Revenue Market Share by Country in 2022
Figure 39. Americas Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
Figure 40. Americas Positive Allosteric Modulators Sales Market Share by Application (2018-2023)
Figure 41. United States Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Positive Allosteric Modulators Sales Market Share by Region in 2022
Figure 46. APAC Positive Allosteric Modulators Revenue Market Share by Regions in 2022
Figure 47. APAC Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
Figure 48. APAC Positive Allosteric Modulators Sales Market Share by Application (2018-2023)
Figure 49. China Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Positive Allosteric Modulators Sales Market Share by Country in 2022
Figure 57. Europe Positive Allosteric Modulators Revenue Market Share by Country in 2022
Figure 58. Europe Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
Figure 59. Europe Positive Allosteric Modulators Sales Market Share by Application (2018-2023)
Figure 60. Germany Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Positive Allosteric Modulators Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Positive Allosteric Modulators Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Positive Allosteric Modulators Sales Market Share by Application (2018-2023)
Figure 69. Egypt Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Positive Allosteric Modulators in 2022
Figure 75. Manufacturing Process Analysis of Positive Allosteric Modulators
Figure 76. Industry Chain Structure of Positive Allosteric Modulators
Figure 77. Channels of Distribution
Figure 78. Global Positive Allosteric Modulators Sales Market Forecast by Region (2024-2029)
Figure 79. Global Positive Allosteric Modulators Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Positive Allosteric Modulators Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Positive Allosteric Modulators Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Positive Allosteric Modulators Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Positive Allosteric Modulators Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Positive Allosteric Modulators
Figure 2. Positive Allosteric Modulators Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Positive Allosteric Modulators Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Positive Allosteric Modulators Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Positive Allosteric Modulators Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Benzodiazepines
Figure 10. Product Picture of Barbiturates
Figure 11. Product Picture of Amantadine
Figure 12. Product Picture of Other
Figure 13. Global Positive Allosteric Modulators Sales Market Share by Type in 2022
Figure 14. Global Positive Allosteric Modulators Revenue Market Share by Type (2018-2023)
Figure 15. Positive Allosteric Modulators Consumed in Parkinson’s Disease
Figure 16. Global Positive Allosteric Modulators Market: Parkinson’s Disease (2018-2023) & (Kiloton)
Figure 17. Positive Allosteric Modulators Consumed in Schizophrenia
Figure 18. Global Positive Allosteric Modulators Market: Schizophrenia (2018-2023) & (Kiloton)
Figure 19. Positive Allosteric Modulators Consumed in Alzheimer’s Disease
Figure 20. Global Positive Allosteric Modulators Market: Alzheimer’s Disease (2018-2023) & (Kiloton)
Figure 21. Global Positive Allosteric Modulators Sales Market Share by Application (2022)
Figure 22. Global Positive Allosteric Modulators Revenue Market Share by Application in 2022
Figure 23. Positive Allosteric Modulators Sales Market by Company in 2022 (Kiloton)
Figure 24. Global Positive Allosteric Modulators Sales Market Share by Company in 2022
Figure 25. Positive Allosteric Modulators Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Positive Allosteric Modulators Revenue Market Share by Company in 2022
Figure 27. Global Positive Allosteric Modulators Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Positive Allosteric Modulators Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Positive Allosteric Modulators Sales 2018-2023 (Kiloton)
Figure 30. Americas Positive Allosteric Modulators Revenue 2018-2023 ($ Millions)
Figure 31. APAC Positive Allosteric Modulators Sales 2018-2023 (Kiloton)
Figure 32. APAC Positive Allosteric Modulators Revenue 2018-2023 ($ Millions)
Figure 33. Europe Positive Allosteric Modulators Sales 2018-2023 (Kiloton)
Figure 34. Europe Positive Allosteric Modulators Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Positive Allosteric Modulators Sales 2018-2023 (Kiloton)
Figure 36. Middle East & Africa Positive Allosteric Modulators Revenue 2018-2023 ($ Millions)
Figure 37. Americas Positive Allosteric Modulators Sales Market Share by Country in 2022
Figure 38. Americas Positive Allosteric Modulators Revenue Market Share by Country in 2022
Figure 39. Americas Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
Figure 40. Americas Positive Allosteric Modulators Sales Market Share by Application (2018-2023)
Figure 41. United States Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Positive Allosteric Modulators Sales Market Share by Region in 2022
Figure 46. APAC Positive Allosteric Modulators Revenue Market Share by Regions in 2022
Figure 47. APAC Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
Figure 48. APAC Positive Allosteric Modulators Sales Market Share by Application (2018-2023)
Figure 49. China Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Positive Allosteric Modulators Sales Market Share by Country in 2022
Figure 57. Europe Positive Allosteric Modulators Revenue Market Share by Country in 2022
Figure 58. Europe Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
Figure 59. Europe Positive Allosteric Modulators Sales Market Share by Application (2018-2023)
Figure 60. Germany Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Positive Allosteric Modulators Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Positive Allosteric Modulators Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Positive Allosteric Modulators Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Positive Allosteric Modulators Sales Market Share by Application (2018-2023)
Figure 69. Egypt Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Positive Allosteric Modulators Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Positive Allosteric Modulators in 2022
Figure 75. Manufacturing Process Analysis of Positive Allosteric Modulators
Figure 76. Industry Chain Structure of Positive Allosteric Modulators
Figure 77. Channels of Distribution
Figure 78. Global Positive Allosteric Modulators Sales Market Forecast by Region (2024-2029)
Figure 79. Global Positive Allosteric Modulators Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Positive Allosteric Modulators Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Positive Allosteric Modulators Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Positive Allosteric Modulators Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Positive Allosteric Modulators Revenue Market Share Forecast by Application (2024-2029)
More Publications
Global Biologic Injectors Market Growth 2024-2030
US$ 3,660.00
November 2024
99 pages
Global Sterile Fill-Finish For Injection Drugs Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
150 pages
Global Intravenous Injection Immunoglobulin Market Growth 2023-2029
US$ 3,660.00
February 2023
93 pages
Global Type I Hyperlipoproteinemia Drug Market Growth 2024-2030
US$ 3,660.00
February 2024
96 pages
Global Computer Aided Detection System Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
120 pages
